President Trump on Thursday night launched TrumpRx, the website he and his aides have touted as a platform aimed at lowering drug prices ...
Roivant and its spinout Priovant said this morning that their immune-modifying drug significantly outperformed placebo in clearing lesions caused by a rare skin disease in a small trial.
The Environmental Working Group, an advocacy group, slammed the announcement as a “retreat” from health secretary Kennedy’s promise to ban synthetic food dyes altogether.
In a small trial, Roivant's immune drug significantly outperformed placebo in clearing lesions caused by a rare skin disease.
Doctors are not a flock of free-range chickens wandering about offices and hospitals and making up best practices, one clinician at the time,” writes Robert Califf.
Test makers and telehealth providers say they want to give people a chance to catch cancers early and seek treatment.
So you’re a bear in the forest, and you’re hungry. When you trundle toward a raspberry bush and get your first taste of ripe, ...
In Denmark, pediatrician Michael Thwing once saw nearly 20 infants admitted simultaneously with rotavirus. His experience in ...
Many people who should be taking statins avoid them for fear of side effects. A large new study says most of those side ...
A STAT analysis found more than 40 hospitals have paused or ceased to offer some gender-affirming care to young people since ...
Novo Nordisk accuses Hims & Hers of ‘illegal mass compounding’ over a cheaper version of Wegovy pill
Hims & Hers is making available a cheaper, compounded version of the Wegovy weight loss pill sold by Novo Nordisk, prompting ...
We discuss financial outlooks from Novo Nordisk and Eli Lilly, a closer look at why manufacturing problems have slowed the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results